The Electrocardiogram After Transcatheter Aortic Valve Replacement Determines the Risk for Post-Procedural High-Degree AV Block and the Need for Telemetry Monitoring

JACC: Cardiovascular Interventions

Volumn 9, Issue 12, 2016, Pages 1269-1276

  Toggweiler, Stefan ^a   Stortecky, Stefan ^b   Holy, Erik ^c   Zuk, Katarzyna ^b   Cuculi, Florim ^a   Nietlispach, Fabian ^c   Sabti, Zaid ^a   Suciu, Raluca ^c   Maier, Willibald ^c   Jamshidi, Peiman ^a   Maisano, Francesco ^c   Windecker, Stephan ^b   Kobza, Richard ^a   Wenaweser, Peter ^b   Lüscher, Thomas F ^c   Binder, Ronald K ^c  

^a LUZERNER KANTONSSPITAL   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

aortic stenosis; conduction disorders; heart block; transcatheter aortic valve replacement

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR RISK; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SEX DIFFERENCE; SINUS RHYTHM; TELEMONITORING; TRANSCATHETER AORTIC VALVE IMPLANTATION; VERY ELDERLY; ADVERSE EFFECTS; ALGORITHM; AMBULATORY ELECTROCARDIOGRAPHY; AORTIC VALVE; ATRIOVENTRICULAR BLOCK; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DECISION SUPPORT SYSTEM; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; SURGERY; SWITZERLAND; TELEMETRY; TIME FACTOR; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALGORITHMS; AORTIC VALVE; ATRIOVENTRICULAR BLOCK; CHI-SQUARE DISTRIBUTION; DECISION SUPPORT TECHNIQUES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SWITZERLAND; TELEMETRY; TIME FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84994049758     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2016.03.024     Document Type: Article

References (23)

1. 1 Linke, A., Wenaweser, P., Gerckens, U., et al. Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. Eur Heart J 35 (2014), 2672–2684.
2. 2 Popma, J.J., Adams, D.H., Reardon, M.J., et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63 (2014), 1972–1981.
3. 3 Wenaweser, P., Stortecky, S., Heg, D., et al. Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry. EuroIntervention 10 (2014), 982–989.
4. 4 Abdel-Wahab, M., Mehilli, J., Frerker, C., et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311 (2014), 1503–1514.
5. 5 Noad, R.L., Johnston, N., McKinley, A., et al. A pathway to earlier discharge following TAVI: assessment of safety and resource utilization. Catheter Cardiovasc Interv, 2015 May 23 [E-pub ahead of print].
6. 6 Genereux, P., Demers, P., Poulin, F., Same day discharge after transcatheter aortic valve replacement: are we there yet?. Catheter Cardiovasc Interv 87 (2016), 980–982.
7. 7 Durand, E., Eltchaninoff, H., Canville, A., et al. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis. Am J Cardiol 115 (2015), 1116–1122.
8. 8 Houthuizen, P., van der Boon, R.M., Urena, M., et al. Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation. EuroIntervention 9 (2014), 1142–1150.
9. 9 Siontis, G.C., Juni, P., Pilgrim, T., et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol 64 (2014), 129–140.
10. 10 van der Boon, R.M., Houthuizen, P., Urena, M., et al. Trends in the occurrence of new conduction abnormalities after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 85 (2015), 144–152.
11. 11 Nazif, T.M., Dizon, J.M., Hahn, R.T., et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. J Am Coll Cardiol Intv 8 (2015), 60–69.
12. 12 Boerlage-Van Dijk, K., Kooiman, K.M., Yong, Z.Y., et al. Predictors and permanency of cardiac conduction disorders and necessity of pacing after transcatheter aortic valve implantation. Pacing Clin Electrophysiol 37 (2014), 1520–1529.
13. 13 Kappetein, A.P., Head, S.J., Genereux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 33 (2012), 2403–2418.
14. 14 Kappetein, A.P., Head, S.J., Genereux, P., et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document. J Am Coll Cardiol 60 (2012), 1438–1454.
15. 15 Tracy, C.M., Pacemaker after transcatheter aortic valve replacement: unexpected, but not infrequent outcome. J Am Coll Cardiol 64 (2014), 141–143.
16. 16 van der Boon, R.M., Van Mieghem, N.M., Theuns, D.A., et al. Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. Int J Cardiol 168 (2013), 1269–1273.
17. 17 Adams, D.H., Popma, J.J., Reardon, M.J., et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370 (2014), 1790–1798.
18. 18 Smith, C.R., Leon, M.B., Mack, M.J., et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364 (2011), 2187–2198.
19. 19 Urena, M., Rodes-Cabau, J., Permanent pacemaker implantation following transcatheter aortic valve replacement: still a concern?. J Am Coll Cardiol Intv 8 (2015), 70–73.
20. 20 Bax, J.J., Delgado, V., Bapat, V., et al. Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. Eur Heart J 35 (2014), 2627–2638.
21. 21 Toggweiler, S., Webb, J.G., Challenges in transcatheter aortic valve implantation. Swiss Med Wkly, 142, 2012, w13735.
22. 22 Binder, R.K., Webb, J.G., Toggweiler, S., et al. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation. J Am Coll Cardiol Intv 6 (2013), 462–468.
23. 23 Mouillet, G., Lellouche, N., Lim, P., et al. Patients without prolonged QRS after TAVI with CoreValve device do not experience high-degree atrio-ventricular block. Catheter Cardiovasc Interv 81 (2013), 882–887.